Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ca(2+)-sensitive cytosolic phospholipase A2 (cPLA2) in human platelets

R M Kramer¹, E F Roberts, J V Manetta

¹Lilly Research Laboratories, Indianapolis, IN.

Journal of Lipid Mediators

|March 1, 1993

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Induction of Diabetes Abolishes the Antithrombotic Effect of Clopidogrel in Apolipoprotein E-Deficient Mice.

TH open : companion journal to thrombosis and haemostasis·2019

Same author

Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelor.

Journal of thrombosis and haemostasis : JTH·2018

Same author

Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor: reply.

Journal of thrombosis and haemostasis : JTH·2018

Same author

Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor.

Journal of thrombosis and haemostasis : JTH·2017

Same author

The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease.

Thrombosis and haemostasis·2014

Same author

Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial.

Thrombosis and haemostasis·2014